March 13, 2026:
Each week, Rewire News Group editors scour headlines nationwide—from lawsuits over abortion access to LGBTQ+ rights—to bring you the most urgent news in reproductive justice. Here’s this week’s latest.
Wyoming abortion advocates challenged a six-week “heartbeat” ban in court this week, one day after Gov. Mark Gordon signed it into law. At six weeks, many people don’t know they’re pregnant, and there is no fetus or heartbeat—only a fetal pole with measurable electrical activity. The lawsuit, filed March 10, was tacked onto another suit against two other, prior anti-abortion laws. Plaintiffs argue that these restrictions violate residents’ right “to make health-care decisions without interference from the government.”
Together, we make reproductive justice visible.
Rewire News Group is a reader-supported, independent nonprofit newsroom. Membership keeps this reporting accessible to all.
Tylenol prescriptions for pregnant women declined in U.S. emergency rooms after President Donald Trump dubiously linked the drug to autism. A study published in The Lancet last week found that ER prescriptions for acetaminophen, Tylenol’s main ingredient, dropped by 10 percent for pregnant patients following Trump’s September 2025 comments but was unchanged for other patients. Data show Tylenol is safe for treating pain and fevers in pregnancy. Prescriptions returned to pre-September levels within months.
It’s legal for West Virginia to exclude gender-affirming surgery from coverage by Medicaid, a federal appeals court in Virginia ruled this week. The ruling—from a panel of mostly Trump-appointed judges—overturned a lower-court decision finding that the state’s law violated federal anti-discrimination protections. Research links gender-affirming surgeries to better mental health. Yet, calling gender-affirming care “ineffective and dangerous,” the ruling said states may reasonably encourage residents to “appreciate their sex.”
This news roundup first appeared in our newsletter, Rewire Weekly. Sign up here to get the latest reproductive rights news, expert analysis, and a peek into the RNG newsroom—fresh to your inbox.